This research report provides a comprehensive analysis of the Chronic Urticaria Or Hives Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Chronic Urticaria Or Hives Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Chronic Urticaria Or Hives Drug, challenges faced by the industry, and potential opportunities for market players.
The global Chronic Urticaria Or Hives Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Chronic Urticaria Or Hives Drug market presents opportunities for various stakeholders, including Clinic, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Chronic Urticaria Or Hives Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Chronic Urticaria Or Hives Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Chronic Urticaria Or Hives Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Chronic Urticaria Or Hives Drug market.
Market Overview: The report provides a comprehensive overview of the Chronic Urticaria Or Hives Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., GDC-0853, GSK-2646264), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Chronic Urticaria Or Hives Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Chronic Urticaria Or Hives Drug market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Chronic Urticaria Or Hives Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Chronic Urticaria Or Hives Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Chronic Urticaria Or Hives Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Chronic Urticaria Or Hives Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Chronic Urticaria Or Hives Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Chronic Urticaria Or Hives Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Chronic Urticaria Or Hives Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Market segment by Application
Clinic
Hospital
Others
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Urticaria Or Hives Drug, market overview.
Chapter 2: Global Chronic Urticaria Or Hives Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Chronic Urticaria Or Hives Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Urticaria Or Hives Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chronic Urticaria Or Hives Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Urticaria Or Hives Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Urticaria Or Hives Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Urticaria Or Hives Drug Overall Market Size
2.1 Global Chronic Urticaria Or Hives Drug Market Size: 2023 VS 2030
2.2 Global Chronic Urticaria Or Hives Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Chronic Urticaria Or Hives Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Chronic Urticaria Or Hives Drug Players in Global Market
3.2 Top Global Chronic Urticaria Or Hives Drug Companies Ranked by Revenue
3.3 Global Chronic Urticaria Or Hives Drug Revenue by Companies
3.4 Global Chronic Urticaria Or Hives Drug Sales by Companies
3.5 Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Chronic Urticaria Or Hives Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Players in Global Market
3.8.1 List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Urticaria Or Hives Drug Market Size Markets, 2023 & 2030
4.1.2 GDC-0853
4.1.3 GSK-2646264
4.1.4 BF-Derm-1
4.1.5 Bilastine
4.1.6 Others
4.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
4.2.1 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2019-2024
4.2.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2025-2030
4.2.3 By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
4.3.1 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2019-2024
4.3.2 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2025-2030
4.3.3 By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
4.4 By Type - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Urticaria Or Hives Drug Market Size, 2023 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
5.2.1 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2019-2024
5.2.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2025-2030
5.2.3 By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
5.3.1 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2019-2024
5.3.2 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2025-2030
5.3.3 By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
5.4 By Application - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Chronic Urticaria Or Hives Drug Market Size, 2023 & 2030
6.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
6.2.1 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2019-2024
6.2.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2025-2030
6.2.3 By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
6.3.1 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2019-2024
6.3.2 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2025-2030
6.3.3 By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Chronic Urticaria Or Hives Drug Revenue, 2019-2030
6.4.2 By Country - North America Chronic Urticaria Or Hives Drug Sales, 2019-2030
6.4.3 US Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.4.4 Canada Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.4.5 Mexico Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Chronic Urticaria Or Hives Drug Revenue, 2019-2030
6.5.2 By Country - Europe Chronic Urticaria Or Hives Drug Sales, 2019-2030
6.5.3 Germany Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5.4 France Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5.5 U.K. Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5.6 Italy Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5.7 Russia Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5.8 Nordic Countries Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.5.9 Benelux Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Chronic Urticaria Or Hives Drug Revenue, 2019-2030
6.6.2 By Region - Asia Chronic Urticaria Or Hives Drug Sales, 2019-2030
6.6.3 China Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.6.4 Japan Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.6.5 South Korea Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.6.6 Southeast Asia Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.6.7 India Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Chronic Urticaria Or Hives Drug Revenue, 2019-2030
6.7.2 By Country - South America Chronic Urticaria Or Hives Drug Sales, 2019-2030
6.7.3 Brazil Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.7.4 Argentina Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, 2019-2030
6.8.3 Turkey Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.8.4 Israel Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Chronic Urticaria Or Hives Drug Market Size, 2019-2030
6.8.6 UAE Chronic Urticaria Or Hives Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Company Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.1.5 AstraZeneca Plc Key News & Latest Developments
7.2 Biofrontera AG
7.2.1 Biofrontera AG Company Summary
7.2.2 Biofrontera AG Business Overview
7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.2.5 Biofrontera AG Key News & Latest Developments
7.3 ELORAC, Inc.
7.3.1 ELORAC, Inc. Company Summary
7.3.2 ELORAC, Inc. Business Overview
7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.3.5 ELORAC, Inc. Key News & Latest Developments
7.4 Faes Farma, SA
7.4.1 Faes Farma, SA Company Summary
7.4.2 Faes Farma, SA Business Overview
7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Major Product Offerings
7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.4.5 Faes Farma, SA Key News & Latest Developments
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Company Summary
7.5.2 Genentech, Inc. Business Overview
7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.5.5 Genentech, Inc. Key News & Latest Developments
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Company Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.6.5 GlaxoSmithKline Plc Key News & Latest Developments
7.7 J Uriach Y Compania, S.A.
7.7.1 J Uriach Y Compania, S.A. Company Summary
7.7.2 J Uriach Y Compania, S.A. Business Overview
7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Major Product Offerings
7.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.7.5 J Uriach Y Compania, S.A. Key News & Latest Developments
7.8 Mabtech Limited
7.8.1 Mabtech Limited Company Summary
7.8.2 Mabtech Limited Business Overview
7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.8.5 Mabtech Limited Key News & Latest Developments
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Company Summary
7.9.2 Merck & Co., Inc. Business Overview
7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.9.5 Merck & Co., Inc. Key News & Latest Developments
7.10 Mycenax Biotech Inc.
7.10.1 Mycenax Biotech Inc. Company Summary
7.10.2 Mycenax Biotech Inc. Business Overview
7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.10.5 Mycenax Biotech Inc. Key News & Latest Developments
7.11 Novartis AG
7.11.1 Novartis AG Company Summary
7.11.2 Novartis AG Business Overview
7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.11.5 Novartis AG Key News & Latest Developments
7.12 Panacea Biotec Limited
7.12.1 Panacea Biotec Limited Company Summary
7.12.2 Panacea Biotec Limited Business Overview
7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2019-2024)
7.12.5 Panacea Biotec Limited Key News & Latest Developments
8 Global Chronic Urticaria Or Hives Drug Production Capacity, Analysis
8.1 Global Chronic Urticaria Or Hives Drug Production Capacity, 2019-2030
8.2 Chronic Urticaria Or Hives Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Urticaria Or Hives Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Urticaria Or Hives Drug Supply Chain Analysis
10.1 Chronic Urticaria Or Hives Drug Industry Value Chain
10.2 Chronic Urticaria Or Hives Drug Upstream Market
10.3 Chronic Urticaria Or Hives Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chronic Urticaria Or Hives Drug in Global Market
Table 2. Top Chronic Urticaria Or Hives Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Chronic Urticaria Or Hives Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Chronic Urticaria Or Hives Drug Revenue Share by Companies, 2019-2024
Table 5. Global Chronic Urticaria Or Hives Drug Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Chronic Urticaria Or Hives Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Chronic Urticaria Or Hives Drug Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 9. List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2019-2024
Table 15. By Type - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2025-2030
Table 16. By Application ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2019-2024
Table 20. By Application - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2025-2030
Table 21. By Region ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2019-2024
Table 25. By Region - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2025-2030
Table 26. By Country - North America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2025-2030
Table 30. By Country - Europe Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2025-2030
Table 34. By Region - Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2025-2030
Table 38. By Country - South America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2025-2030
Table 42. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2025-2030
Table 46. AstraZeneca Plc Company Summary
Table 47. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offerings
Table 48. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. AstraZeneca Plc Key News & Latest Developments
Table 50. Biofrontera AG Company Summary
Table 51. Biofrontera AG Chronic Urticaria Or Hives Drug Product Offerings
Table 52. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. Biofrontera AG Key News & Latest Developments
Table 54. ELORAC, Inc. Company Summary
Table 55. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 56. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. ELORAC, Inc. Key News & Latest Developments
Table 58. Faes Farma, SA Company Summary
Table 59. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offerings
Table 60. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Faes Farma, SA Key News & Latest Developments
Table 62. Genentech, Inc. Company Summary
Table 63. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 64. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. Genentech, Inc. Key News & Latest Developments
Table 66. GlaxoSmithKline Plc Company Summary
Table 67. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offerings
Table 68. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. GlaxoSmithKline Plc Key News & Latest Developments
Table 70. J Uriach Y Compania, S.A. Company Summary
Table 71. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offerings
Table 72. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. J Uriach Y Compania, S.A. Key News & Latest Developments
Table 74. Mabtech Limited Company Summary
Table 75. Mabtech Limited Chronic Urticaria Or Hives Drug Product Offerings
Table 76. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Mabtech Limited Key News & Latest Developments
Table 78. Merck & Co., Inc. Company Summary
Table 79. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 80. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Merck & Co., Inc. Key News & Latest Developments
Table 82. Mycenax Biotech Inc. Company Summary
Table 83. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 84. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Mycenax Biotech Inc. Key News & Latest Developments
Table 86. Novartis AG Company Summary
Table 87. Novartis AG Chronic Urticaria Or Hives Drug Product Offerings
Table 88. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 89. Novartis AG Key News & Latest Developments
Table 90. Panacea Biotec Limited Company Summary
Table 91. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offerings
Table 92. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 93. Panacea Biotec Limited Key News & Latest Developments
Table 94. Chronic Urticaria Or Hives Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2022-2024 (K Pcs)
Table 95. Global Chronic Urticaria Or Hives Drug Capacity Market Share of Key Manufacturers, 2022-2024
Table 96. Global Chronic Urticaria Or Hives Drug Production by Region, 2019-2024 (K Pcs)
Table 97. Global Chronic Urticaria Or Hives Drug Production by Region, 2025-2030 (K Pcs)
Table 98. Chronic Urticaria Or Hives Drug Market Opportunities & Trends in Global Market
Table 99. Chronic Urticaria Or Hives Drug Market Drivers in Global Market
Table 100. Chronic Urticaria Or Hives Drug Market Restraints in Global Market
Table 101. Chronic Urticaria Or Hives Drug Raw Materials
Table 102. Chronic Urticaria Or Hives Drug Raw Materials Suppliers in Global Market
Table 103. Typical Chronic Urticaria Or Hives Drug Downstream
Table 104. Chronic Urticaria Or Hives Drug Downstream Clients in Global Market
Table 105. Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Segment by Type in 2023
Figure 2. Chronic Urticaria Or Hives Drug Segment by Application in 2023
Figure 3. Global Chronic Urticaria Or Hives Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Chronic Urticaria Or Hives Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Chronic Urticaria Or Hives Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Chronic Urticaria Or Hives Drug Sales in Global Market: 2019-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Urticaria Or Hives Drug Revenue in 2023
Figure 9. By Type - Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Chronic Urticaria Or Hives Drug Price (USD/Pcs), 2019-2030
Figure 13. By Application - Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Chronic Urticaria Or Hives Drug Price (USD/Pcs), 2019-2030
Figure 17. By Region - Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 23. US Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 28. Germany Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 37. China Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 44. Brazil Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share, 2019-2030
Figure 48. Turkey Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Chronic Urticaria Or Hives Drug Production Capacity (K Pcs), 2019-2030
Figure 53. The Percentage of Production Chronic Urticaria Or Hives Drug by Region, 2023 VS 2030
Figure 54. Chronic Urticaria Or Hives Drug Industry Value Chain
Figure 55. Marketing Channels
